Mednax Holding Co: (NYSE: MD)

$92.27

-0.21 (-0.23%)

Volume 187,907

Jun 18 04:04 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		92.13 - 92.64
	
		52wk Low - High
		60.90 - 94.58
	
		Previous Close
		92.48
	
		Avg. Volume
		199,372
	
		Industry
		MED-HOSPITALS
	
		Market Cap
		4.64 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		1.06
	
		P/E (F1)
		17.07
	
		Current Year Est.
		5.42
	
		Quarterly Earnings ESP 
		-1.46%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		49 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 06/14/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            P/E (F1)
                            17.07
                        
                            PEG Ratio
                            1.21
                        
                            Current Year Est.
                            5.42
                        
                            Current Quarter Estimate
                            1.37
                        
                            Most Accurate Estimate
                            1.35
                        
                            Earnings ESP 
                            -1.46%
                        
                            Next Earnings Report Date
                            08-06-2013
                        
                            EPS Last Year
                            4.96
                        
                            Expected Earnings Growth
                            14.08%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services  in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives.   
Full MD Company Report

 Snapshot on MD

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
MD Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	1.37	1.47	5.42	6.00
Number of Estimates	9	9	10	9
Low Estimate	1.34	1.41	5.27	5.83
High Estimate	1.47	1.60	5.70	NA
Year Ago EPS	1.22	1.32	4.85	5.42
EPS Growth	12.30%	11.70%	11.71%	10.80%

More MD Estimates

Average Earnings Estimates for MD

EPS Growth for MD

Industry Analysis

Name	Symbol	Previous Close
MEDNAX INC	MD	92.48
VCA ANTECH INC	WOOF	26.07
ACADIA HEALTHCR	ACHC	34.21
COMMNTY HLTH SY	CYH	49.66
HCA HOLDINGS	HCA	39.26
HEALTH MGT ASSC	HMA	16.06
LIFEPOINT HOSP	LPNT	51.53
TENET HEALTH	THC	45.52
UNIVL HLTH SVCS	UHS	69.91
VANGUARD HEALTH	VHS	13.07

Sector:Medical>> Industry:MED-HOSPITALS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Tenet to Buy Emanuel Medical Center

Feb 27, 2013

Tenet Prices Senior Notes

Jan 25, 2013

Tenet Raised to Outperform

Jan 24, 2013

Report for MD

Jun 14, 2013

More MD Zacks Commentary

Financials

EPS TTM	4.96
Sales	1,817
Net Income	248
Price/Earnings	18.65
Price/Book	2.20
Price/Cash Flow	16.96
Price/Sales	2.45

More MD Financials

News

Increased Dividends, Quality Health Management Services, Strategic Acquisitions, and Cost-Effective Healthcare Solutions - Research Report on UnitedHealth, Aetna, Cigna, WellCare, and MEDNAX - Pr Newswire

Jun 17, 2013

MEDNAX to Present at the Wells Fargo Securities Healthcare Conference in Boston - Businesswire

Jun 14, 2013

Mednax Purchases Anesthesiology Practice in New York - Close-Up Media

Jun 14, 2013

MEDNAX Inc acquires Anesthesia Group of Onondaga in New York, making entry into ninth state - M2

Jun 12, 2013

MEDNAX Acquires Anesthesia Group of Onondaga - Benzinga

Jun 11, 2013

MEDNAX Announces Acquisition of Anesthesiology Practice in New York - Businesswire

Jun 11, 2013

MEDNAX acquires Anesthesia Group of Onondaga - Datamonitor Financial Deals Tracker

Jun 11, 2013

Top 3 Companies in the Health Care Services Industry With the Highest Revenue Per Employee (ESRX, AMS, MD) - Financial News Network Online - News Corner

Jun 10, 2013

See All News Stories on MD

Broker Recommendations

Current ABR	2.00
ABR (Last Week)	2.00
# of recs in ABR	12
Average Target Price	95.20
Industry Rank by ABR	49 out of 265
Rank in Industry	3 out of 10

More MD Broker Recommendations

Username: Password:

Remember me [?]

Forgot Password

New Member

Mednax Holding Co: (NYSE: MD)

$92.27

-0.21 (-0.23%)

Volume 187,907

Jun 18 04:04 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED-HOSPITALS

Zacks Commentary

Tenet to Buy Emanuel Medical Center

Tenet Prices Senior Notes

Tenet Raised to Outperform

Report for MD

Financials

News

Increased Dividends, Quality Health Management Services, Strategic Acquisitions, and Cost-Effective Healthcare Solutions - Research Report on UnitedHealth, Aetna, Cigna, WellCare, and MEDNAX - Pr Newswire

MEDNAX to Present at the Wells Fargo Securities Healthcare Conference in Boston - Businesswire

Mednax Purchases Anesthesiology Practice in New York - Close-Up Media

MEDNAX Inc acquires Anesthesia Group of Onondaga in New York, making entry into ninth state - M2

MEDNAX Acquires Anesthesia Group of Onondaga - Benzinga

MEDNAX Announces Acquisition of Anesthesiology Practice in New York - Businesswire

MEDNAX acquires Anesthesia Group of Onondaga - Datamonitor Financial Deals Tracker

Top 3 Companies in the Health Care Services Industry With the Highest Revenue Per Employee (ESRX, AMS, MD) - Financial News Network Online - News Corner

Broker Recommendations

Day Low - High	92.13 - 92.64
52wk Low - High	60.90 - 94.58
Previous Close	92.48
Avg. Volume	199,372
Industry	MED-HOSPITALS
Market Cap	4.64 B
Div - Yield	0.00 - 0.00
Beta	1.06
P/E (F1)	17.07
Current Year Est.	5.42
Quarterly Earnings ESP	-1.46%

P/E (F1)	17.07
PEG Ratio	1.21
Current Year Est.	5.42
Current Quarter Estimate	1.37
Most Accurate Estimate	1.35
Earnings ESP	-1.46%
Next Earnings Report Date	08-06-2013
EPS Last Year	4.96
Expected Earnings Growth	14.08%